Russell Investments Group Ltd. Grows Stake in Phreesia, Inc. (NYSE:PHR)

Russell Investments Group Ltd. boosted its position in shares of Phreesia, Inc. (NYSE:PHR) by 2.5% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 126,587 shares of the company’s stock after purchasing an additional 3,089 shares during the quarter. Russell Investments Group Ltd.’s holdings in Phreesia were worth $7,808,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently made changes to their positions in the company. Nisa Investment Advisors LLC increased its holdings in shares of Phreesia by 23.0% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,140 shares of the company’s stock valued at $132,000 after acquiring an additional 400 shares during the period. Amalgamated Bank increased its holdings in shares of Phreesia by 20.5% in the 3rd quarter. Amalgamated Bank now owns 8,677 shares of the company’s stock valued at $535,000 after acquiring an additional 1,478 shares during the period. Prudential Financial Inc. increased its holdings in shares of Phreesia by 16.6% in the 2nd quarter. Prudential Financial Inc. now owns 63,864 shares of the company’s stock valued at $3,915,000 after acquiring an additional 9,084 shares during the period. Baird Financial Group Inc. increased its holdings in shares of Phreesia by 43.9% in the 2nd quarter. Baird Financial Group Inc. now owns 27,988 shares of the company’s stock valued at $1,716,000 after acquiring an additional 8,543 shares during the period. Finally, OLD Mission Capital LLC purchased a new position in shares of Phreesia in the 2nd quarter valued at $333,000. Institutional investors and hedge funds own 95.78% of the company’s stock.

Shares of PHR opened at $35.55 on Friday. The stock has a 50-day moving average of $51.55 and a two-hundred day moving average of $61.14. Phreesia, Inc. has a one year low of $33.65 and a one year high of $81.59. The company has a debt-to-equity ratio of 0.01, a quick ratio of 7.15 and a current ratio of 7.15. The stock has a market cap of $1.82 billion, a P/E ratio of -22.08 and a beta of 1.27.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Wednesday, December 8th. The company reported ($0.46) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.47) by $0.01. Phreesia had a negative return on equity of 18.66% and a negative net margin of 40.51%. The company had revenue of $55.90 million during the quarter, compared to analysts’ expectations of $48.75 million. During the same quarter in the previous year, the firm posted ($0.17) EPS. The firm’s revenue was up 45.2% compared to the same quarter last year. Analysts predict that Phreesia, Inc. will post -2.49 EPS for the current fiscal year.

In other Phreesia news, SVP Amy Beth Vanduyn sold 10,834 shares of Phreesia stock in a transaction dated Thursday, October 21st. The stock was sold at an average price of $35.00, for a total transaction of $379,190.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP David Linetsky sold 5,451 shares of Phreesia stock in a transaction dated Monday, November 1st. The shares were sold at an average price of $70.88, for a total value of $386,366.88. The disclosure for this sale can be found here. Insiders have sold a total of 21,262 shares of company stock valued at $1,139,533 in the last quarter. Company insiders own 5.60% of the company’s stock.

A number of brokerages have recently issued reports on PHR. Needham & Company LLC cut their price target on Phreesia from $81.00 to $65.00 and set a “buy” rating on the stock in a report on Thursday, December 9th. Citigroup lowered their price objective on Phreesia from $72.00 to $54.00 and set a “neutral” rating for the company in a research report on Friday, December 10th. Royal Bank of Canada lowered their price objective on Phreesia from $60.00 to $51.00 and set a “sector perform” rating for the company in a research report on Thursday, December 9th. Jefferies Financial Group initiated coverage on Phreesia in a research report on Wednesday, December 1st. They issued a “buy” rating and a $70.00 price objective for the company. Finally, SVB Leerink cut Phreesia from an “outperform” rating to a “market perform” rating and lowered their price objective for the stock from $57.00 to $41.00 in a research report on Thursday, January 6th. Four equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $64.15.

Phreesia Profile

Phreesia, Inc is a healthcare software company, which engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products.

Featured Story: What is a Call Option?

Want to see what other hedge funds are holding PHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phreesia, Inc. (NYSE:PHR).

Institutional Ownership by Quarter for Phreesia (NYSE:PHR)

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.